Tumor protein D52 (TPD52): A novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI
Articolo
Data di Pubblicazione:
2005
Citazione:
Tumor protein D52 (TPD52): A novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI / E. Tiacci, P. Orvietani, B. Bigerna, A. Pucciarini, G.L. Corthals, V. Pettirossi, M.P. Martelli, A. Liso, R. Benedetti, R. Pacini, N. Bolli, S. Pileri, K. Pulford, M. Gambacorta, A. Carbone, C. Pasquarello, A. Scherl, H. Robertson, M.T. Sciurpi, G. Alunni-Bistocchi, L. Binaglia, J.A. Byrne, B. Falini. - In: BLOOD. - ISSN 0006-4971. - 105:7(2005), pp. 2812-2820.
Abstract:
We generated a murine monoclonal antibody (B28p) detecting an antigenic determinant shared by the immunoglobulin superfamily receptor translocation-associated 1 (IRTA1) receptor (the immunogen used to raise B28p) and an unrelated 28-kDa protein that was subsequently subjected to extensive characterization. The expression of the 28-kDa protein in normal lymphohematopoietic tissues was restricted to B cells and plasma cells and clearly differed from that expected for IRTA1 (selectively expressed by mucosa-associated lymphoid tissue [MALT] marginal zone B cells). Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)/mass-spectrometry analysis identified the 28-kDa protein as human tumor protein D52 (TPD52), whose expression had been previously described only in normal and neoplastic epithelia. Specific B28p reactivity with TPD52 was confirmed by immunostaining/immunoblotting of TPD52-transfected cells. TPD52 expression pattern in normal and neoplastic B cells was unique. In fact, unlike other B-cell molecules (paired box 5 [PAX5], CD19, CD79a, CD20, CD22), which are down-regulated during differentiation from B cells to plasma cells, TPD52 expression reached its maximum levels at the plasma cell stage. In the Thiel myeloma cell line, TPD52 bound to annexin VI in a Ca2+-dependent manner, suggesting that these molecules may act in concert to regulate secretory processes in plasma cells, similarly to what was observed in pancreatic acinar cells. Finally, the anti-TPD52 monoclonal antibody served as a valuable tool for the diagnosis of B-cell malignancies.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Reed-sternberg cells; plasma-cells; lymphoblastic lymphoma; monoclonal-antibodies; breast-carcinoma; acinar-cells; copy number; gene family; identification; hodgkin
Elenco autori:
E. Tiacci, P. Orvietani, B. Bigerna, A. Pucciarini, G.L. Corthals, V. Pettirossi, M.P. Martelli, A. Liso, R. Benedetti, R. Pacini, N. Bolli, S. Pileri, K. Pulford, M. Gambacorta, A. Carbone, C. Pasquarello, A. Scherl, H. Robertson, M.T. Sciurpi, G. Alunni-Bistocchi, L. Binaglia, J.A. Byrne, B. Falini
Link alla scheda completa:
Link al Full Text: